Literature DB >> 29882133

Markers of Inflammation.

Dori R Germolec1, Kelly A Shipkowski2, Rachel P Frawley2, Ellen Evans3.   

Abstract

Inflammation is a complex and necessary component of the response to biological, chemical, or physical stimuli, and the cellular and molecular events that initiate and regulate the interactions between the various players in the inflammatory process remain a source of ongoing investigation. In the acute phase of the inflammatory response, cells of the immune system migrate to the site of injury in a carefully orchestrated sequence of events that is facilitated by soluble mediators such as cytokines, chemokines, and acute-phase proteins. Depending on the degree of injury, this acute phase may be sufficient to resolve the damage and initiate healing processes. Persistent inflammation, either as a result of prolonged exposure to stimulation or an inappropriate reaction against self-molecules, can lead to the chronic phase, in which tissue damage and fibrosis can occur. Chronic inflammation has been reported to contribute to numerous diseases, including arthritis, asthma, atherosclerosis, autoimmune diseases, diabetes, and cancer, and to conditions of aging. Hematology and clinical chemistry data from standard toxicology studies can provide an initial indication of the presence and sometimes the location of inflammation. These data may suggest more specific immune function assays that are necessary to determine the presence and/or mechanism(s) of immunomodulation. Although changes in hematology dynamics, acute-phase proteins, complement factors, and cytokines are common to virtually all inflammatory conditions, and can be measured by a variety of techniques, individual biomarkers have yet to be strongly associated with specific pathologic events. Thus, although sensitive indicators of inflammation, these factors generally lack the specificity to identify the offending cause. The profile seen in a given inflammatory condition is dependent on the severity, chronicity, and mechanisms involved in the inflammatory process, as well as the species and the capacity of the individual's immune system to respond and adapt.

Entities:  

Keywords:  Acute-phase proteins; Basophil; Chemokine; Clinical pathology; Complement; Cytokine; Eosinophil; Hematology; Inflammation; Lymphocyte; Macrophage; Monocyte; Neutrophil; Platelet

Mesh:

Substances:

Year:  2018        PMID: 29882133     DOI: 10.1007/978-1-4939-8549-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

1.  Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation?

Authors:  Osmar Vieira Ramires Junior; Tiago Marcon Dos Santos; Josiane Silva Silveira; Raíssa Leite-Aguiar; Robson Coutinho-Silva; Luiz Eduardo Baggio Savio; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2022-05-17       Impact factor: 5.590

2.  Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes.

Authors:  Elaine Luiza Santos Soares de Mendonça; João Victor Farias da Silva; Carolina Santos Mello; Alane Cabral Menezes de Oliveira
Journal:  Arch Gynecol Obstet       Date:  2022-01-07       Impact factor: 2.344

Review 3.  Male infertility and somatic health - insights into lipid damage as a mechanistic link.

Authors:  Nathan D Burke; Brett Nixon; Shaun D Roman; John E Schjenken; Jessica L H Walters; R John Aitken; Elizabeth G Bromfield
Journal:  Nat Rev Urol       Date:  2022-09-13       Impact factor: 16.430

Review 4.  Serum biomarkers for the assessment of muscle damage in various surgical approaches in primary total hip arthroplasty: a systematic review of comparative studies.

Authors:  Michael G Sarantis; Panagiotis I Mandrekas; Sophia Stasi; Konstantinos Makris; George A Macheras; Andreas F Mavrogenis; George C Babis; Vasilios S Nikolaou
Journal:  Int Orthop       Date:  2022-06-01       Impact factor: 3.479

Review 5.  Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.

Authors:  Ivan K Domingo; Asna Latif; Amit P Bhavsar
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

6.  Zingerone Mitigates Carrageenan-Induced Inflammation Through Antioxidant and Anti-inflammatory Activities.

Authors:  Saeed Mehrzadi; Hamidreza Khalili; Iman Fatemi; Alireza Malayeri; Amir Siahpoosh; Mehdi Goudarzi
Journal:  Inflammation       Date:  2021-02       Impact factor: 4.092

Review 7.  Beyond weight loss: current perspectives on the impact of calorie restriction on healthspan and lifespan.

Authors:  Maryam Kebbe; Joshua R Sparks; Emily W Flanagan; Leanne M Redman
Journal:  Expert Rev Endocrinol Metab       Date:  2021-05-07

8.  Association of inflammatory markers with cerebral small vessel disease in community-based population.

Authors:  Lingling Jiang; Xueli Cai; Dongxiao Yao; Jing Jing; Lerong Mei; Yingying Yang; Shan Li; Aoming Jin; Xia Meng; Hao Li; Tiemin Wei; Yongjun Wang; Yuesong Pan; Yilong Wang
Journal:  J Neuroinflammation       Date:  2022-05-06       Impact factor: 9.587

Review 9.  Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC50 Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components.

Authors:  Mona Abdel-Tawab
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-06

Review 10.  Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention.

Authors:  Xudong Zhu; Zhiyang Chen; Weiyan Shen; Gang Huang; John M Sedivy; Hu Wang; Zhenyu Ju
Journal:  Signal Transduct Target Ther       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.